Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome
Moore, A., Burrows, A.K.ORCID: 0000-0001-9293-1352, Malik, R., Ghubash, R.M., Last, R.D. and Remaj, B.
(2022)
Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome.
Veterinary Dermatology
.
Early View.
*No subscription required
Abstract
Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6-year-old, feline immunodeficiency virus-positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.
Item Type: | Journal Article |
---|---|
Murdoch Affiliation(s): | Veterinary Medicine |
Publisher: | John Wiley & Sons Ltd on behalf of ESVD and ACVD. |
Copyright: | © 2022 The Authors. |
URI: | http://researchrepository.murdoch.edu.au/id/eprint/65062 |
![]() |
Item Control Page |
Downloads
Downloads per month over past year